A research team led by scientists from the Broad Institute has uncovered a novel group of chemical inhibitors that can kill the bacteria that causes tuberculosis (TB). Importantly, these chemical compounds take aim at a previously unexplored molecular target, paving a potential path toward an entirely new class of antibiotics, which are profoundly needed to combat the worldwide problem of drug resistance in TB.
* This article was originally published here
